Kura Oncology, Inc. logo

Kura Oncology, Inc.

NASDAQ:KURA

Overview | Financials
Company Name Kura Oncology, Inc.
Symbol KURA
Currency USD
Price 18.09
Market Cap 1,386,318,105
Dividend Yield 0%
52-week-range 7.41 - 24.17
Industry Biotechnology
Sector Healthcare
CEO Dr. Troy Edward Wilson J.D., Ph.D.
Website https://kuraoncology.com

An error occurred while fetching data.

About Kura Oncology, Inc.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the

Related Stocks

FibroGen, Inc. logo

FibroGen, Inc.

FGEN

0.395 USD

Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

ACRS

1.17 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

12.28 USD

Cutera, Inc. logo

Cutera, Inc.

CUTR

0.664 USD

Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

SANA

4.06 USD

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

39.32 USD

Avid Bioservices, Inc. logo

Avid Bioservices, Inc.

CDMO

10.15 USD

Phibro Animal Health Corporation logo

Phibro Animal Health Corporation

PAHC

24.36 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

19.89 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

61.09 USD

Financials

Numbers are in millions USD

Numbers are in millions USD